Actemra 160mg, a drug known scientifically as tocilizumab, represents a potent pharmaceutical agent primarily utilized for the control of rheumatoid arthritis. This powerful agent functions by blocking the activity of interleukin-6 (IL-6), a regulatory protein crucial in the inflammatory process. Additionally, Actemra demonstrates effectiveness in